DPP4 and colorectal carcinoma: Hence, this study plans to investigate the potential therapeutic potential of DPP4-inhibitor on CRC patients by comparing the prognosis of post-operative CRC patients with diabetes complications and treated with DPP4-inhibitor to those treated with metformin and investigate the association with immune cell profile.